Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2024
WuXi AppTec national-security controversy
WuXi AppTec became a focus of United States national-security and biotechnology-supply-chain concerns. The BIOSECURE Act passed by the U.S. House of Representatives specifically named the company in provisions concerning entities alleged to have ties to a foreign adversary's military, internal-security forces, or intelligence agencies. Li co-signed a February 2024 letter rejecting broad allegations and preemptive measures, while external analyses examined his participation in Chinese Communist Party-related activities and WuXi's role in China's strategic science and technology objectives.